DE3807594C2 - - Google Patents

Info

Publication number
DE3807594C2
DE3807594C2 DE3807594A DE3807594A DE3807594C2 DE 3807594 C2 DE3807594 C2 DE 3807594C2 DE 3807594 A DE3807594 A DE 3807594A DE 3807594 A DE3807594 A DE 3807594A DE 3807594 C2 DE3807594 C2 DE 3807594C2
Authority
DE
Germany
Prior art keywords
antibodies
oligosaccharide
cells
glycoproteins
mannose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3807594A
Other languages
German (de)
English (en)
Other versions
DE3807594A1 (de
Inventor
Werner Prof. Dr. Reutter
Rolf Dr. Nuck
Martin 1000 Berlin De Zimmermann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DE3807594A priority Critical patent/DE3807594A1/de
Application filed by Individual filed Critical Individual
Priority to DE19883844628 priority patent/DE3844628C2/de
Priority to JP1502832A priority patent/JP2693247B2/ja
Priority to AT89903099T priority patent/ATE90793T1/de
Priority to EP89903099A priority patent/EP0406259B1/de
Priority to DE8989903099T priority patent/DE58904746D1/de
Priority to PCT/DE1989/000146 priority patent/WO1989008845A1/de
Publication of DE3807594A1 publication Critical patent/DE3807594A1/de
Application granted granted Critical
Publication of DE3807594C2 publication Critical patent/DE3807594C2/de
Priority to US08/128,264 priority patent/US5625037A/en
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/303—Liver or Pancreas
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE3807594A 1988-03-08 1988-03-08 Antikoerper, verfahren zu ihrer herstellung, oligosaccharid-haptene und klone zur erzeugung der antikoerper sowie verwendung der antikoerper zur diagnose und therapie von tumoren Granted DE3807594A1 (de)

Priority Applications (8)

Application Number Priority Date Filing Date Title
DE19883844628 DE3844628C2 (en) 1988-03-08 1988-03-08 New antibodies reactive with N-glycan structures of cell membrane surf
DE3807594A DE3807594A1 (de) 1988-03-08 1988-03-08 Antikoerper, verfahren zu ihrer herstellung, oligosaccharid-haptene und klone zur erzeugung der antikoerper sowie verwendung der antikoerper zur diagnose und therapie von tumoren
AT89903099T ATE90793T1 (de) 1988-03-08 1989-03-08 Antikoerper, verfahren zu ihrer herstellung, klone zur erzeugung der antikoerper sowie verwendung der antikoerper zur diagnose und therapie von tumoren.
EP89903099A EP0406259B1 (de) 1988-03-08 1989-03-08 Antikörper, verfahren zu ihrer herstellung, klone zur erzeugung der antikörper sowie verwendung der antikörper zur diagnose und therapie von tumoren
JP1502832A JP2693247B2 (ja) 1988-03-08 1989-03-08 抗体の製造方法
DE8989903099T DE58904746D1 (de) 1988-03-08 1989-03-08 Antikoerper, verfahren zu ihrer herstellung, klone zur erzeugung der antikoerper sowie verwendung der antikoerper zur diagnose und therapie von tumoren.
PCT/DE1989/000146 WO1989008845A1 (en) 1988-03-08 1989-03-08 Antibodies, process for producing them, oligosaccharide haptens and clones for the production of the antibodies, and use of the antibodies for diagnosis and therapy of tumours
US08/128,264 US5625037A (en) 1988-03-08 1993-09-28 Antibodies, method of preparing same, oligosaccharides and clones for providing said antibodies, and the use of said antibodies for tumor diagnosis and therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3807594A DE3807594A1 (de) 1988-03-08 1988-03-08 Antikoerper, verfahren zu ihrer herstellung, oligosaccharid-haptene und klone zur erzeugung der antikoerper sowie verwendung der antikoerper zur diagnose und therapie von tumoren

Publications (2)

Publication Number Publication Date
DE3807594A1 DE3807594A1 (de) 1989-09-21
DE3807594C2 true DE3807594C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-04-22

Family

ID=6349168

Family Applications (2)

Application Number Title Priority Date Filing Date
DE3807594A Granted DE3807594A1 (de) 1988-03-08 1988-03-08 Antikoerper, verfahren zu ihrer herstellung, oligosaccharid-haptene und klone zur erzeugung der antikoerper sowie verwendung der antikoerper zur diagnose und therapie von tumoren
DE8989903099T Expired - Fee Related DE58904746D1 (de) 1988-03-08 1989-03-08 Antikoerper, verfahren zu ihrer herstellung, klone zur erzeugung der antikoerper sowie verwendung der antikoerper zur diagnose und therapie von tumoren.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE8989903099T Expired - Fee Related DE58904746D1 (de) 1988-03-08 1989-03-08 Antikoerper, verfahren zu ihrer herstellung, klone zur erzeugung der antikoerper sowie verwendung der antikoerper zur diagnose und therapie von tumoren.

Country Status (4)

Country Link
EP (1) EP0406259B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP2693247B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (2) DE3807594A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO1989008845A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20011671L (fi) 2001-08-20 2003-02-21 Carbion Oy Tuumorispesifiset oligosakkaridisekvenssit ja niiden käyttö
AU2003255544A1 (en) * 2002-08-20 2004-03-11 Biotie Therapies Corp. Tumor specific oligosaccharide epitopes and use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894442A (en) * 1985-04-12 1990-01-16 Kuraray Co., Ltd. Monoclonal antibodies that bind to alpha-acid glycoprotein

Also Published As

Publication number Publication date
DE58904746D1 (de) 1993-07-22
JPH03503281A (ja) 1991-07-25
JP2693247B2 (ja) 1997-12-24
WO1989008845A1 (en) 1989-09-21
EP0406259B1 (de) 1993-06-16
EP0406259A1 (de) 1991-01-09
DE3807594A1 (de) 1989-09-21

Similar Documents

Publication Publication Date Title
Stoward et al. Histochemical reactivity of peanut lectin-horseradish peroxidase conjugate.
Fredman et al. Monoclonal antibody A2B5 reacts with many gangliosides in neuronal tissue
DE3854194T2 (de) Monoklonale antikörper gegen glykosyliertes albumin, hybride zellinien, die diese antikörper produzieren, sowie deren verwendung.
DE3586262T2 (de) Monoklonale antikoerper und antigen fuer menschliche lungenkarzinome vom nichtkleinen zellentyp.
US4507391A (en) Method for detecting the presence of GD3 ganglioside
DE69306803T2 (de) Kleinzelliger lungenkarzinom-spezifischer antikörper und antigenen
EP0480440B1 (de) Monoklonale Antikörper gegen Melanom
DE68912403T2 (de) Monoklonaler Antikörper, spezifisch für eine in transformierten Zellen exprimierte Fibronectin-Sequenz, Hybridoma, das diesen Antikörper erzeugt und Verwendung dieses monoklonalen Antikörpers zur Diagnose von Tumoren.
DE69737298T2 (de) Konjugate von polysacchariden und biomolekülen
JPH03103190A (ja) 腫瘍関連ガングリオシド及びフコガングリオシドに対するモノクローナル抗体及びその製造法
NO853397L (no) Nye monoklonale antistoffer til glykokonjugater, fremgangsmaate til fremstilling derav og anvendelser av antistoffene.
DD276165A5 (de) Verfahren zur detektion maligner zellen
DE69701811T2 (de) Cyclitol enthaltende kohlenhydrate aus menschlichem gewebe, die deren glycogen-stoffwechsel regulieren
DE69701812T2 (de) Cyclitol enthaltende kohlenhydrate aus menschlichem gewebe, die die lipogenese-aktivität regulieren
DE3807594C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE69029270T2 (de) HYBRIDOMA CT43, DAS EIN ANTIKöRPER GEGEN EIN MUCINEPITOP VON DARMKREBS ERZEUGT
DE3688638T2 (de) Monoklonale Antikörper für humane Lungenkarzinome des "Nicht-kleine-Zellen"-Typs.
DE3844628C2 (en) New antibodies reactive with N-glycan structures of cell membrane surf
DE3850634T2 (de) Alpha 2-3-Verbindungen erkennender monoklonaler Antikörper.
DE10138935B4 (de) Synthetische Verbindungen vom Nicht-Mucintyp oder ihre mit einem Träger konjugierten Verbindungen, unter deren Verwendung hergestellte monoclonale Antikörper, diese umfassende Antitumormittel Immunstimulantien und Mittel gegen das humane Immundefizienzvirus
EP0326073A1 (de) Hapten-Protein-Konjugate und ihre Verwendung
WO2003040185A2 (de) Anti-n-glykolyl-neuraminsäure-antikörper und ihre verwendung zur bestimmung von glykoproteinen
DE69110067T2 (de) Monoklonale Antikörper gegen nicht-A 1C glykosyliertes Hämoglobin.
DE69324776T2 (de) Pharmazeutische Zusammensetzung die krebserkennende Antikörper enthält
DE69836279T2 (de) Neue Verbindung, 2-Amino-3-[2-(α-Mannopyranosyl)indol-3-YL] Propionsäure, Verfahren zur Herstellung und Methoden zur in Vivo Untersuchung mit der neuen Verbindung

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
8181 Inventor (new situation)

Free format text: REUTTER, WERNER, PROF. DR. NUCK, ROLF, DR. ZIMMERMANN, MARTIN, 1000 BERLIN, DE

8172 Supplementary division/partition in:

Ref country code: DE

Ref document number: 3844628

Format of ref document f/p: P

Q171 Divided out to:

Ref country code: DE

Ref document number: 3844628

AH Division in

Ref country code: DE

Ref document number: 3844628

Format of ref document f/p: P

D2 Grant after examination
AH Division in

Ref country code: DE

Ref document number: 3844628

Format of ref document f/p: P

8364 No opposition during term of opposition
8320 Willingness to grant licences declared (paragraph 23)
8339 Ceased/non-payment of the annual fee